Department of Neurology 707A, Huzhou Central Hospital, Affiliated Central Hospital of HuZhou University, Huzhou, Zhejiang China.
Department of Neurology 707A, Huzhou Central Hospital, Affiliated Central Hospital of HuZhou University, Huzhou, Zhejiang China.
World Neurosurg. 2024 Aug;188:e194-e206. doi: 10.1016/j.wneu.2024.05.081. Epub 2024 May 20.
Acute subdural hematoma (ASDH) is a common critical neurosurgical condition, often requiring immediate surgical intervention. Craniotomy and decompressive craniectomy are the 2 mainstay surgical approaches. This comprehensive review and meta-analysis aims to summarize the existing evidence and compare the outcomes of these 2 procedures.
PubMed, Embase, Cochrane Central Register of Controlled Trials, and CINAHL electronic databases were searched for relevant studies, published between inception of databases till June 2023. Eligible studies reported data of patients diagnosed with ASDH who underwent craniotomy or decompressive craniectomy for ASDH. Outcome measures included the Glasgow Coma Scale score, residual subdural hematoma, requirement of revision surgery, poorer outcomes, and mortality. Data were presented as pooled odds ratios with 95% confidence intervals. Quality assessment and risk of bias were performed for each study.
Fourteen studies with a total of 3095 patients were included. The results showed that patients who underwent craniotomy had significantly lower mortality, lower odds of poorer outcomes, and a higher rate of residual subdural hematoma, compared to patients who underwent decompressive craniectomy. There was no significant difference in the requirement of revision surgery between the 2 groups. Heterogeneity was high for most outcomes, and the quality of evidence ranged from moderate to low.
Our findings suggest that craniotomy is associated with better clinical outcomes and lower mortality compared to decompressive craniectomy for ASDH, but a higher rate of residual subdural hematoma. Further high-quality randomized controlled trials are needed to validate our findings.
急性硬膜下血肿(ASDH)是一种常见的危急神经外科病症,常需立即进行手术干预。开颅术和去骨瓣减压术是两种主要的手术方法。本综述和荟萃分析旨在总结现有证据,并比较这两种手术方法的结果。
检索了 PubMed、Embase、Cochrane 对照试验中心注册库和 CINAHL 电子数据库,以获取截至 2023 年 6 月发表的关于诊断为 ASDH 并接受开颅术或去骨瓣减压术治疗 ASDH 的患者的相关研究。纳入的研究报告了接受开颅术或去骨瓣减压术治疗 ASDH 的患者的数据。结局指标包括格拉斯哥昏迷评分、硬膜下血肿残留、需要再次手术、较差结局和死亡率。数据以合并优势比(OR)及其 95%置信区间(CI)呈现。对每项研究进行了质量评估和偏倚风险评估。
共纳入 14 项研究,总计 3095 例患者。结果表明,与接受去骨瓣减压术的患者相比,接受开颅术的患者死亡率更低,较差结局的可能性更小,硬膜下血肿残留的发生率更高。两组患者再次手术的需求无显著差异。大多数结局的异质性较高,证据质量从中等至低等不等。
与去骨瓣减压术相比,开颅术治疗 ASDH 可获得更好的临床结局和更低的死亡率,但硬膜下血肿残留的发生率更高。需要进一步开展高质量的随机对照试验来验证我们的研究结果。